In subcutaneously implanted groups, knockdown of PRMT5 resulted in a significant reduction in tumor growth (Fig. 2C), whereas overexpression of PRMT5 showed the opposite result (Fig. 2D). This evidence concerns the gene PRMT5 and neoplasm.